Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells
Anja Meyer(University of Illinois Chicago), Shiva Shahrara(University of Illinois Chicago), Shiva Arami(University of Illinois Chicago), Sadiq Umar(University of Illinois Chicago), Myles Lewis(Queen Mary University of London), Katrien Van Raemdonck(Rega Institute for Medical Research), Costantino Pitzalis(Queen Mary University of London), Brian Zanotti(Midwestern University), Georg Schett(Karolinska University Hospital), Pim Jetanalin(University of Illinois Chicago), Wes Nijim(University of Illinois Chicago), Michael V. Volin(Midwestern University), Nadera Sweiss(University of Illinois Chicago), Mina Al‐Awqati(University of Illinois Chicago), Huan J. Chang(Chengdu Medical College), Ryan E Sienes(University of Illinois Chicago)
Cited by 26
Related Papers
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
|Nature Immunology|2019|1.4k
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
|Journal of Clinical Investigation|2012|708
EULAR definition of difficult-to-treat rheumatoid arthritis
|Annals of the Rheumatic Diseases|2020|538